UTHR logo
United Therapeutics Corporation(UTHR)
Closing price · checked 9:22 AM ETAbout this dataData status
$593.31▼-2.35 (-0.39%)
Pre-Market:$593.64+0.33 (+0.06%)

United Therapeutics Corporation (UTHR)

R&D to Revenue

17.28%

Fiscal year · Period ending:

UTHR logo

UTHR R&D to Revenue

Latest reported17.28%
UTHR FY R&D/Revenue (11000.00% → 17.28%)
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

UTHR r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

United Therapeutics Corporation R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
17.2809%
16.7165%
17.5295%
16.6761%
32.0439%
24.1151%
81.6262%
21.9867%
15.3365%
9.2319%
16.7216%
18.8239%
26.7997%
18.9271%
24.2222%
27.6172%
33.0374%
84.9675%
39.514%
36.0642%
31.1021%
41.5845%
66.3973%
88.9044%
568.5953%
3,425.0323%
7,675%
11,000%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.